Concepedia

Mildred Ugozzoli

MU

33

Publications

2.2K

Citations

28

H-Index

1998

Active since

Affiliations

Novartis (United States)(Current)

Itron (United States)

Chiron (Norway)

Novartis (Italy)

Novartis (Switzerland)

Mildred Ugozzoli is an author at Novartis (United States) specializing in medicine, immunology, and vaccination.

Top concepts

MedicineImmunologyVaccinationVaccine DevelopmentEngineeringImmunotherapyNanomedicineCross-protectionAllergyInfection Control

Publications per year

1998–2020

33

Publications

33

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice

Andreas Wack, Barbara C. Baudner, Anne Katrin Hilbert et al. · Vaccine · 2008 · 193 citations

Vaccination, Cross-protection, Long-lasting Antibody +14

Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection

Marc Dupuis, Thomas J. Murphy, Deborah Higgins et al. · Cellular Immunology · 1998 · 182 citations

Vaccination, Cross-protection, Vaccine Development +6

Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines

Derek T. O’Hagan, Manmohan Singh, Mildred Ugozzoli et al. · Journal of Virology · 2001 · 178 citations · Full text

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency

Jina Kazzaz, Manmohan Singh, Mildred Ugozzoli et al. · Journal of Controlled Release · 2005 · 118 citations

Cell-based Drug Delivery, Nanomedicine, Medicine +8

Cationic Microparticles Are an Effective Delivery System for Immune Stimulatory CpG DNA

Manmohan Singh, Gary Ott, Jina Kazzaz et al. · Pharmaceutical Research · 2001 · 115 citations

Rows per page

1–5 of 33